This viewpoint reflects on the ACURATE platform withdrawal, noting trial limitations, procedural factors, and promising registry data.
#TAVI #Cardiosky #PCRLV
eurointervention.pcronline.com/article/disc...
Early results of the DurAVR THV in small aortic annuli show excellent 30-day performance: low gradients, large EOAs, minimal PPM and no mortality.
SIMULTANEOUS PUBLICATION #PCRLV @CARDIOSKY
eurointervention.pcronline.com/article/thir...
🚀 Live from #PCRLV!
Dr. Juan F. Granada is moderating the Top Late-Breaking Trials session spotlighting the latest data and advancements shaping structural heart care.
#CardioSky #MedSky
Tchétché et al sign a must-read SOTA on TAVI in bicuspid AS in EuroIntervention: anatomy, sizing, device choice, pitfalls, and what we still don’t know about durability & TAVI vs SAVR. #TAVI #BAV #PCRLV
eurointervention.pcronline.com/article/tran...
Tchétché et al sign a must-read SOTA on TAVI in bicuspid AS in EuroIntervention: anatomy, sizing, device choice, pitfalls, and what we still don’t know about durability & #TAVI vs SAVR.
#BAV #PCRLV #cardiosky
eurointervention.pcronline.com/article/tran...
New PCR London Valves issue!
Highlights: SOTA on TAVI in bicuspid AS, EHRA/EAPCI tricuspid consensus, ACURATE Viewpoint, new data on Evolut FX cannulation, SAPIEN RESILIA HALT, TRICURE FIH, 5-yr EVOQUE TTVR & more. #PCRLV #cardiosky
eurointervention.pcronline.com/issue/volume...
#PCRLV reached to an end and it was a combination of innovation, evidence, case based discussion & LBCTs which will affect our clinical practice - Stay tuned here www.pcronline.com #CardioSky #MedSky
Super proud of this booklet on #echofirst #PCRtricuspid which will be launched duration #PCRLV - pick up your copy 📚